• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

James Chih-Hsin Yang - Articles and news items

Boehringer Ingelheim logo

New efficacy and safety data adds to evidence suppoith afatinib*(GIOTRIF®) in Asian and non-Asian lung cancer patients

Industry news / 27 October 2013 / Boehringer Ingelheim

“The new sub-analysis confirms the consistent safety profile of afatinib in Asian patients…”

Boehringer Ingelheim logo
Boehringer Ingelheim logo
Boehringer Ingelheim logo

Afatinib* delivers unprecedented first line efficacy in patients with EGFR mutation positive lung cancer in registration trial

Industry news, News / 4 June 2012 / Boehringer Ingelheim

LUX-Lung 3 results highlighted at the official ASCO Press Conference…


Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringFIND OUT MORE
+ +